FIELD: chemistry.
SUBSTANCE: compounds under the present invention are characterised by properties of aurora-kinase-A and/or aurora-kinase-B inhibitor. In general formula (I) 
: A represents 5-merous heteroaryl containing two nitrogen atoms; X represents NR14; m represents 0, 1, 2 or 3; Z represents the group chosen from -NR1R2, and 4-7-merous saturated ring connected by carbon atom containing nitrogen atom and substituted at nitrogen atom with C1-C4alkyl substituted by phosphonoxy; R1 represents C1-C6-alkyl substituted by phosphonoxy; R2 represents the group chosen from hydrogen, C1-C6-alkyl where C1-C6-alkyl is optionally substituted with 1, 2 or 3 halogen or C1-C4-alkoxy groups, or R2 represents the group chosen from C2-C6-alkenyl, C2-C6-alkinyl, C3-C6-cycloalkyl and C3-C6-cycloalkyl-C1-C4alkyl; or R1 and R2 together with nitrogen atom whereto attached form 4-7-merous saturated ring substituted at carbon or nitrogen atom by the group chosen from phosphonoxy and C1-C4-alkyl where C1-C4alkyl is substituted by phosphonoxy; R3 represents the group chosen from hydrogen, halogen, C1-C6-alkoxy; R4 represents phenyl substituted with 1-2 halogens; R5, R6, R7 and R14 represent hydrogen. In addition, the invention concerns the pharmaceutical composition containing therapeutically active amount of the compound under the invention, to application of the compound for preparation of a medical product applied in therapy of disease wherefore inhibition of one or more aurora-kinases is efficient, to method treatment, as well as production of the compounds under the invention.
EFFECT: high-yield end product.
26 cl, 5 tbl, 50 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PHOSPHONOOXYQUINAZOLINE DERIVATIVES AND THEIR PHARMACEUTICAL APPLICATION | 2003 |
|
RU2350611C1 |
| SUBSTITUTED DERIVATIVES OF QUINAZOLINE AS AURORAKINASE INHIBITORS | 2002 |
|
RU2323215C2 |
| QUINAZOLINE DERIVATIVES | 2004 |
|
RU2370494C2 |
| QUINOLINE DERIVATIVES AS TYROSINE KINASE INHIBITORS | 2004 |
|
RU2378268C2 |
| CARBOXAMIDE COMPOUNDS AND USE THEREOF AS CALPAIN INHIBITORS | 2007 |
|
RU2485114C2 |
| QUINAZOLINE COMPOUNDS | 2003 |
|
RU2365588C2 |
| CERTAIN CHEMICAL COMPOUNDS, COMPOSITIONS AND METHODS | 2014 |
|
RU2718876C2 |
| JAK KINASE-MODULATING QUINAZOLINE DERIVATIVES AND METHODS OF APPLYING THEREOF | 2010 |
|
RU2529019C2 |
| OXYGEN-SUBSTITUTED DERIVATIVES OF 3-HETEROAROYLAMINOPROPIONIC ACIDS AND THEIR APPLICATION AS PHARMACEUTICAL SUBSTANCES | 2011 |
|
RU2561126C2 |
| METHODS AND COMPOSITIONS FOR IMPROVING COGNITIVE FUNCTIONS | 2012 |
|
RU2665021C2 |
